NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Anthropic PBC Updates Claude AI Chatbot Features

Key Highlights

  • Anthropic PBC has introduced a context recall feature for free users of its Claude AI chatbot, a move aimed at retaining new consumers who have driven unprecedented demand.
  • The company has also simplified the process for new subscribers to import prior histories from other AI chatbots, such as ChatGPT, via a simple copy-and-paste technique.

Business Update

Read also: Google Pixel Watch Leak: Diver's Discovery Sparks Speculation

Anthropic has seen a significant increase in attention for its consumer products following a high-profile clash with the US Defense Department over the potential use of its technology for mass surveillance and autonomous weaponry. In response, President Donald Trump ordered US government agencies to remove Claude from their systems, and the Pentagon declared Anthropic a supply-chain risk, threatening its business.

User Growth

  • Claude's free active users have grown more than 60% since January.
  • Daily signups have quadrupled since January.
  • On Monday, Claude experienced an hourslong service disruption due to unprecedented demand, but the issue was resolved by midmorning New York time.

Industry Developments

Read also: Chinese Startup Claims AI Coding Capabilities Exceed Those of GPT-5.5: A Detailed Examination

  • OpenAI has announced plans to deploy its own AI models within the Defense Department's classified network, prompting some users to call for a boycott of ChatGPT.

Investor Takeaway

Anthropic is enhancing its AI chatbot, Claude, to compete with ChatGPT, which may positively impact its consumer product offerings.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.